Dr. Perla Lansang

Dermatologist, Toronto, ON

Dr. Perla Lansang is a full-time staff dermatologist and associate professor in the Division of Dermatology, University of Toronto where she is the Division Head of Dermatology at Sunnybrook Health Sciences Centre. She is also cross appointed at the Section of Paediatric Dermatology at the Hospital for Sick Children, and the Division of Obstetric Medicine at Sunnybrook Health Sciences Centre.
She completed her medical school and dermatology residency at the University of the Philippines-Philippine General Hospital. Having done fellowships in paediatric dermatology at The Hospital for Sick Children and in advanced medical dermatology at Sunnybrook Health Sciences Centre, Dr. Lansang’s practice is a mixture of pediatric, adolescent, and adult dermatology, with a special focus on psoriasis, atopic dermatitis, cutaneous lymphoma, pregnancy dermatoses, and general medical dermatology. She has a special interest in immune-mediated skin diseases and has extensive clinical and research experience in many areas of immunodermatology.

10:30 AM - 11:20 AM

SAT Apr 29

Make It PsO: The Next Generation of Topical Treatments

Objectives of the session:

  1. Discuss unmet needs for topical treatments in the management of the chronic disease plaque psoriasis (PsO) from patients’ and physicians’ perspectives.
  2. Review the benefits and challenges of current plaque PsO topical treatment approaches.
  3. Examine next generation topical formulation considerations for the practical management of chronic plaque PsO.

Summary description of the session:

Join us for the second episode of PsO Let’s Talk with our expert guest host, Dr. Perla Lansang. For the past 60 years, topical therapies remain the foundation of chronic plaque PsO treatment, yet many unmet needs still exist. A novel non-steroidal topical treatment option has not been approved in Canada for over 20 years. Plaque PsO is a heterogenous and chronic disease, with almost 90% of patients experiencing PsO in more than one location with a median disease duration of 50 years; however, no one topical therapy safely addresses all affected areas and there are growing concerns, real and perceived, from patients as steroid-phobia continues to gain presence in many social media outlets. Dermatologists often need to prescribe PsO patients a complex regimen consisting of at least 2-3 different topicals of varying potencies, of which many may have treatment limitations due to adverse events compromising their acceptance by patients for chronic use. Additionally, despite the many currently available topical treatments, patients with plaque PsO still experience the highly disruptive symptom of itch that negatively affects their quality of life.

This open session will discuss current and new developments in topical treatment for chronic plaque PsO by examining efficacy, safety/tolerability, and vehicle formulation considerations towards the clinical goal for a simplified regimen. The expert speaker panel from the final frontier, Dr. Kim ‘Papp-card’ and Dr. ‘Bones’ Turchin, will ‘Make It PsO’ the audience gains a better understanding of the ongoing challenges in the management of this chronic auto-immune inflammatory skin condition, and how this next generation of topical non-steroidal therapy may address these unmet needs.